Masimo (NASDAQ: MASI) immediately introduced that Peter J. Pronovost, MD, PhD, Chief High quality and Medical Transformation Officer at College Hospitals in Cleveland (UH), has been named a “High 25 Innovator” by Modern Healthcare for his contribution to College Hospitals’ launch of the Masimo SafetyNet™ distant affected person administration resolution for individuals who examined optimistic for COVID-19.
This press launch options multimedia. View the total launch right here: https://www.businesswire.com/news/home/20200902005819/en/
Dr. Peter Pronovost with Masimo SafetyNet™ (Photograph: Enterprise Wire)
Lengthy acknowledged all through the for his experience and innovation in affected person security and high quality of care, Pronovost led a group earlier this 12 months to pilot Masimo SafetyNet, a safe telehealth resolution that mixes tetherless Masimo SET® pulse oximetry with a distant affected person surveillance platform programmed with a COVID-19 care protocol. “Masimo SafetyNet was transformational in serving to us reply to the pandemic by offering UH an modern, high-value approach to assist us put together for a possible surge in affected person quantity,” stated Pronovost.
Since its preliminary deployment in March, Masimo SafetyNet has expanded to permit steady temperature measurement utilizing the tetherless Radius Tº™ sensor. Masimo SafetyNet is now in use at greater than 130 establishments around the globe.
Joe Kiani, Founder and CEO of Masimo, commented, “Dr. Pronovost, along with his pioneering work on Masimo SafetyNet, has helped pave the way in which to avoid wasting the lives of COVID-19 sufferers—a testomony to his imaginative and prescient and dedication. On behalf of the various 1000’s who’ve benefited and who will profit from his ardour and brilliance over the span of his profession, I’m thrilled to congratulate him on this well-deserved honor. His values align carefully with Masimo’s dedication to enhancing affected person outcomes and lowering the price of care.”
@MasimoInnovates | #Masimo
Masimo (NASDAQ: MASI) is a world medical know-how firm that develops and produces a big selection of industry-leading monitoring applied sciences, together with modern measurements, sensors, affected person displays, and automation and connectivity options. Our mission is to enhance affected person outcomes and cut back the price of care. Masimo SET® Measure-through Movement and Low Perfusion™ pulse oximetry, launched in 1995, has been proven in over 100 unbiased and goal research to outperform different pulse oximetry applied sciences.1 Masimo SET® has additionally been proven to assist clinicians cut back extreme retinopathy of prematurity in neonates,2 enhance CCHD screening in newborns,three and, when used for steady monitoring with Masimo Affected person SafetyNet™ in post-surgical wards, cut back speedy response group activations, ICU transfers, and prices.Four-7 Masimo SET® is estimated for use on greater than 200 million sufferers in main hospitals and different healthcare settings around the globe,eight and is the first pulse oximetry at 9 of the highest 10 hospitals in response to the 2020-21 U.S. Information and World Report Greatest Hospitals Honor Roll.9 Masimo continues to refine SET® and in 2018, introduced that SpO2 accuracy on RD SET® sensors throughout circumstances of movement has been considerably improved, offering clinicians with even higher confidence that the SpO2 values they depend on precisely replicate a affected person’s physiological standing. In 2005, Masimo launched rainbow® Pulse CO-Oximetry know-how, permitting noninvasive and steady monitoring of blood constituents that beforehand might solely be measured invasively, together with complete hemoglobin (SpHb®), oxygen content material (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen Reserve Index (ORi™). In 2013, Masimo launched the Root® Affected person Monitoring and Connectivity Platform, constructed from the bottom as much as be as versatile and expandable as potential to facilitate the addition of different Masimo and third-party monitoring applied sciences; key Masimo additions embody Subsequent Era SedLine® Mind Operate Monitoring, O3® Regional Oximetry, and ISA™ Capnography with NomoLine® sampling strains. Masimo’s household of steady and spot-check monitoring Pulse CO-Oximeters® contains gadgets designed to be used in quite a lot of medical and non-clinical situations, together with tetherless, wearable know-how, corresponding to Radius-7® and Radius PPG™, transportable gadgets like Rad-67™, fingertip pulse oximeters like MightySat® Rx, and gadgets accessible to be used each within the hospital and at residence, corresponding to Rad-97®. Masimo hospital automation and connectivity options are centered across the Masimo Hospital Automation™ platform, and embody Iris Gateway®, Affected person SafetyNet, Duplicate™, Halo ION™, UniView™, UniView: 60™, and Masimo SafetyNet™. Further details about Masimo and its merchandise could also be discovered at www.masimo.com. Printed medical research on Masimo merchandise may be discovered at www.masimo.com/evidence/featured-studies/feature/.
ORi and RPVi haven’t acquired FDA 510(okay) clearance and should not accessible on the market in america. Using the trademark Affected person SafetyNet is below license from College HealthSystem Consortium.
- Printed medical research on pulse oximetry and the advantages of Masimo SET® may be discovered on our web site at http://www.masimo.com. Comparative research embody unbiased and goal research that are comprised of abstracts introduced at scientific conferences and peer-reviewed journal articles.
- Castillo A et al. Prevention of Retinopathy of Prematurity in Preterm Infants by way of Adjustments in Medical Apply and SpO2 Know-how. Acta Paediatr. 2011 Feb;100(2):188-92.
- de-Wahl Granelli A et al. Impression of pulse oximetry screening on the detection of duct dependent congenital coronary heart illness: a Swedish potential screening examine in 39,821 newborns. BMJ. 2009;Jan eight;338.
- Taenzer A et al. Impression of pulse oximetry surveillance on rescue occasions and intensive care unit transfers: a before-and-after concurrence examine. Anesthesiology. 2010:112(2):282-287.
- Taenzer A et al. Postoperative Monitoring – The Dartmouth Expertise. Anesthesia Affected person Security Basis E-newsletter. Spring-Summer season 2012.
- McGrath S et al. Surveillance Monitoring Administration for Basic Care Models: Technique, Design, and Implementation. The Joint Fee Journal on High quality and Affected person Security. 2016 Jul;42(7):293-302.
- McGrath S et al. Inpatient Respiratory Arrest Related With Sedative and Analgesic Drugs: Impression of Steady Monitoring on Affected person Mortality and Extreme Morbidity. J Affected person Saf. 2020 14 Mar. DOI: 10.1097/PTS.0000000000000696.
- Estimate: Masimo knowledge on file.
This press launch contains forward-looking statements as outlined in Part 27A of the Securities Act of 1933 and Part 21E of the Securities Trade Act of 1934, in reference to the Non-public Securities Litigation Reform Act of 1995. These forward-looking statements embody, amongst others, statements relating to the potential effectiveness of Masimo SafetyNet™. These forward-looking statements are based mostly on present expectations about future occasions affecting us and are topic to dangers and uncertainties, all of that are tough to foretell and plenty of of that are past our management and will trigger our precise outcomes to vary materially and adversely from these expressed in our forward-looking statements on account of varied danger elements, together with, however not restricted to: dangers associated to our assumptions relating to the repeatability of medical outcomes; dangers associated to our perception that Masimo’s distinctive noninvasive measurement applied sciences, together with Masimo SafetyNet, contribute to optimistic medical outcomes and affected person security; dangers associated to our perception that Masimo noninvasive medical breakthroughs present cost-effective options and distinctive benefits; dangers associated to COVID-19; in addition to different elements mentioned within the “Threat Components” part of our most up-to-date reviews filed with the Securities and Trade Fee (“SEC”), which can be obtained at no cost on the SEC’s web site at www.sec.gov. Though we consider that the expectations mirrored in our forward-looking statements are affordable, we have no idea whether or not our expectations will show right. All forward-looking statements included on this press launch are expressly certified of their entirety by the foregoing cautionary statements. You might be cautioned to not place undue reliance on these forward-looking statements, which converse solely as of immediately’s date. We don’t undertake any obligation to replace, amend or make clear these statements or the “Threat Components” contained in our most up-to-date reviews filed with the SEC, whether or not on account of new info, future occasions or in any other case, besides as could also be required below the relevant securities legal guidelines.